Mercer Global Advisors
ONCY

Mercer Global Advisors’s Oncolytics Biotech ONCY Stock Holding History

Mercer Global Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597 Buy
+628
New +$582 ﹤0.01% 5808

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Mercer Global Advisors's ONCY Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 628 shares worth $597. The stake represents ﹤0.01% of the portfolio and ranks #5808 among its holdings.

55 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Mercer Global Advisors held 628 shares of Oncolytics Biotech worth $597 as of Q2 2026.
  • Oncolytics Biotech was a new Mercer Global Advisors position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5808 holding.
  • 55 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.